about
Treatment of anxiety disorders in epilepsy: an evidence-based approachObsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder.Obsessive-compulsive disorder: An interface with possible psychotic featuresNormalisation of immune cell imbalance after pharmacological treatments of patients suffering from obsessive-compulsive disorder.Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder.
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pharmacotherapy for obsessive-compulsive disorder.
@ast
Pharmacotherapy for obsessive-compulsive disorder.
@en
Pharmacotherapy for obsessive-compulsive disorder.
@nl
type
label
Pharmacotherapy for obsessive-compulsive disorder.
@ast
Pharmacotherapy for obsessive-compulsive disorder.
@en
Pharmacotherapy for obsessive-compulsive disorder.
@nl
prefLabel
Pharmacotherapy for obsessive-compulsive disorder.
@ast
Pharmacotherapy for obsessive-compulsive disorder.
@en
Pharmacotherapy for obsessive-compulsive disorder.
@nl
P2093
P1476
Pharmacotherapy for obsessive-compulsive disorder.
@en
P2093
P304
P356
10.1016/S0193-953X(05)70186-6
P577
2000-09-01T00:00:00Z